Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-09-001408
Filing Date
2009-02-18
Accepted
2009-02-18 17:01:14
Documents
12

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS, INC. c06286b6sv1za.htm S-1/A 1895959
2 EX-10.11 c06286b6exv10w11.htm EX-10.11 24339
3 EX-10.12 c06286b6exv10w12.htm EX-10.12 24427
4 EX-10.13 c06286b6exv10w13.htm EX-10.13 24337
5 EX-10.14 c06286b6exv10w14.htm EX-10.14 24307
6 EX-10.15 c06286b6exv10w15.htm EX-10.15 24935
7 EX-10.16 c06286b6exv10w16.htm EX-10.16 225914
8 EX-23.1 c06286b6exv23w1.htm EX-23.1 2640
9 EX-23.3 c06286b6exv23w3.htm EX-23.3 3007
10 GRAPHIC c06286b6c0628602.gif GRAPHIC 3768
11 GRAPHIC c06286b6c0628600.gif GRAPHIC 5123
12 GRAPHIC c06286b6c0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-09-001408.txt   2264399
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 09619212
SIC: 2834 Pharmaceutical Preparations